BB Biotech Financial Overview
BB Biotech's market cap is currently CHF2.50B. The company's EPS TTM is CHF8.16; its P/E ratio is 15.17; BB Biotech is scheduled to report earnings on October 24, 2025, and the estimated EPS forecast is CHF―. See an overview of income statement, balance sheet, and cash flow financials.
